vs

Side-by-side financial comparison of OCEANFIRST FINANCIAL CORP (OCFC) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.

OCEANFIRST FINANCIAL CORP is the larger business by last-quarter revenue ($104.7M vs $75.5M, roughly 1.4× PUMA BIOTECHNOLOGY, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 9.6%). OCEANFIRST FINANCIAL CORP produced more free cash flow last quarter ($79.5M vs $14.4M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 3.1%).

OceanFirst Bank N.A. is an American regional bank subsidiary of the U.S. financial services holding company OceanFirst Financial Corp. founded and headquartered in Ocean County, New Jersey, with operations throughout New Jersey, and in the major metropolitan markets of Philadelphia, New York City, Baltimore, Boston, Washington D.C.

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

OCFC vs PBYI — Head-to-Head

Bigger by revenue
OCFC
OCFC
1.4× larger
OCFC
$104.7M
$75.5M
PBYI
Growing faster (revenue YoY)
PBYI
PBYI
+18.2% gap
PBYI
27.7%
9.6%
OCFC
More free cash flow
OCFC
OCFC
$65.1M more FCF
OCFC
$79.5M
$14.4M
PBYI
Faster 2-yr revenue CAGR
PBYI
PBYI
Annualised
PBYI
31.3%
3.1%
OCFC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
OCFC
OCFC
PBYI
PBYI
Revenue
$104.7M
$75.5M
Net Profit
$13.1M
Gross Margin
69.3%
Operating Margin
16.1%
22.7%
Net Margin
12.5%
Revenue YoY
9.6%
27.7%
Net Profit YoY
-40.2%
EPS (diluted)
$0.24
$0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
OCFC
OCFC
PBYI
PBYI
Q4 25
$104.7M
$75.5M
Q3 25
$103.0M
$54.5M
Q2 25
$99.4M
$52.4M
Q1 25
$97.9M
$46.0M
Q4 24
$95.6M
$59.1M
Q3 24
$96.9M
$80.5M
Q2 24
$93.2M
$47.1M
Q1 24
$98.5M
$43.8M
Net Profit
OCFC
OCFC
PBYI
PBYI
Q4 25
$13.1M
Q3 25
$17.3M
$8.8M
Q2 25
$19.0M
$5.9M
Q1 25
$21.5M
$3.0M
Q4 24
$21.9M
Q3 24
$25.1M
$20.3M
Q2 24
$24.4M
$-4.5M
Q1 24
$28.7M
$-4.8M
Gross Margin
OCFC
OCFC
PBYI
PBYI
Q4 25
69.3%
Q3 25
77.7%
Q2 25
76.5%
Q1 25
77.1%
Q4 24
76.4%
Q3 24
63.9%
Q2 24
77.4%
Q1 24
75.5%
Operating Margin
OCFC
OCFC
PBYI
PBYI
Q4 25
16.1%
22.7%
Q3 25
21.9%
17.6%
Q2 25
25.0%
12.7%
Q1 25
28.9%
8.7%
Q4 24
28.5%
22.6%
Q3 24
33.7%
27.4%
Q2 24
33.8%
-4.6%
Q1 24
39.8%
-5.3%
Net Margin
OCFC
OCFC
PBYI
PBYI
Q4 25
12.5%
Q3 25
16.8%
16.2%
Q2 25
19.2%
11.2%
Q1 25
22.0%
6.5%
Q4 24
22.9%
Q3 24
25.9%
25.2%
Q2 24
26.1%
-9.6%
Q1 24
29.1%
-11.0%
EPS (diluted)
OCFC
OCFC
PBYI
PBYI
Q4 25
$0.24
$0.26
Q3 25
$0.30
$0.17
Q2 25
$0.28
$0.12
Q1 25
$0.35
$0.06
Q4 24
$0.36
$0.40
Q3 24
$0.42
$0.41
Q2 24
$0.40
$-0.09
Q1 24
$0.47
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
OCFC
OCFC
PBYI
PBYI
Cash + ST InvestmentsLiquidity on hand
$97.5M
Total DebtLower is stronger
$255.2M
$22.7M
Stockholders' EquityBook value
$1.7B
$130.3M
Total Assets
$14.6B
$216.3M
Debt / EquityLower = less leverage
0.15×
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
OCFC
OCFC
PBYI
PBYI
Q4 25
$97.5M
Q3 25
$94.4M
Q2 25
$96.0M
Q1 25
$93.2M
Q4 24
$101.0M
Q3 24
$96.7M
Q2 24
$96.8M
Q1 24
$107.2M
Total Debt
OCFC
OCFC
PBYI
PBYI
Q4 25
$255.2M
$22.7M
Q3 25
$34.0M
Q2 25
$45.3M
Q1 25
$56.7M
Q4 24
$197.5M
$68.0M
Q3 24
$79.3M
Q2 24
$90.7M
Q1 24
$102.0M
Stockholders' Equity
OCFC
OCFC
PBYI
PBYI
Q4 25
$1.7B
$130.3M
Q3 25
$1.7B
$115.3M
Q2 25
$1.6B
$104.7M
Q1 25
$1.7B
$97.1M
Q4 24
$1.7B
$92.1M
Q3 24
$1.7B
$71.1M
Q2 24
$1.7B
$48.5M
Q1 24
$1.7B
$51.0M
Total Assets
OCFC
OCFC
PBYI
PBYI
Q4 25
$14.6B
$216.3M
Q3 25
$14.3B
$202.9M
Q2 25
$13.3B
$194.9M
Q1 25
$13.3B
$196.2M
Q4 24
$13.4B
$213.3M
Q3 24
$13.5B
$220.7M
Q2 24
$13.3B
$205.0M
Q1 24
$13.4B
$214.1M
Debt / Equity
OCFC
OCFC
PBYI
PBYI
Q4 25
0.15×
0.17×
Q3 25
0.30×
Q2 25
0.43×
Q1 25
0.58×
Q4 24
0.12×
0.74×
Q3 24
1.12×
Q2 24
1.87×
Q1 24
2.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
OCFC
OCFC
PBYI
PBYI
Operating Cash FlowLast quarter
$87.2M
$14.4M
Free Cash FlowOCF − Capex
$79.5M
$14.4M
FCF MarginFCF / Revenue
75.9%
19.1%
Capex IntensityCapex / Revenue
7.4%
0.0%
Cash ConversionOCF / Net Profit
6.66×
TTM Free Cash FlowTrailing 4 quarters
$125.9M
$41.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
OCFC
OCFC
PBYI
PBYI
Q4 25
$87.2M
$14.4M
Q3 25
$24.4M
$9.7M
Q2 25
$28.6M
$14.1M
Q1 25
$-1.8M
$3.6M
Q4 24
$92.2M
$15.6M
Q3 24
$-22.4M
$11.0M
Q2 24
$23.7M
$1.0M
Q1 24
$46.1M
$11.2M
Free Cash Flow
OCFC
OCFC
PBYI
PBYI
Q4 25
$79.5M
$14.4M
Q3 25
$22.8M
$9.7M
Q2 25
$27.2M
$14.1M
Q1 25
$-3.6M
$3.6M
Q4 24
$84.7M
$15.6M
Q3 24
$-23.5M
$11.0M
Q2 24
$19.5M
$1.0M
Q1 24
$45.4M
FCF Margin
OCFC
OCFC
PBYI
PBYI
Q4 25
75.9%
19.1%
Q3 25
22.2%
17.7%
Q2 25
27.4%
26.8%
Q1 25
-3.7%
7.7%
Q4 24
88.6%
26.4%
Q3 24
-24.2%
13.7%
Q2 24
20.9%
2.1%
Q1 24
46.1%
Capex Intensity
OCFC
OCFC
PBYI
PBYI
Q4 25
7.4%
0.0%
Q3 25
1.5%
0.0%
Q2 25
1.4%
0.0%
Q1 25
1.9%
0.1%
Q4 24
7.9%
0.0%
Q3 24
1.1%
0.0%
Q2 24
4.5%
0.0%
Q1 24
0.7%
0.0%
Cash Conversion
OCFC
OCFC
PBYI
PBYI
Q4 25
6.66×
Q3 25
1.41×
1.10×
Q2 25
1.50×
2.41×
Q1 25
-0.08×
1.21×
Q4 24
4.21×
Q3 24
-0.89×
0.54×
Q2 24
0.97×
Q1 24
1.61×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons